Profil
Andreas Rutger Segerros is currently Chief Executive Officer at Sylentis SAU since 2024.
Holds Chairman positions at Oncorena AB, Dextech Medical AB, and Oncorena Holding AB. Serves as Director at Prexton Therapeutics SA. Managing Partner at Eir Ventures Danmark ApS since 2020.
Formerly Chief Executive Officer at Nicox SA from 2022 to 2024.
Served as Chief Executive Officer at Clinitrac AB. Held Chairman role at CMC Contrast AB. Worked as Independent Director at Zyla Life Sciences LLC.
Director at Egalet Ltd. in 2011.
Director at RSPR Pharma AB. Head of Business Development & Operations Planning at Ferring Pharmaceuticals A. Principal at Pharmacia, Inc. Venture Partner at Sunstone Capital A from 2012 to 2019.
Education includes an MBA from the University of Uppsala and graduate studies at the Royal Institute of Technology.
Aktiva positioner av Andreas Segerros
| Företag | Position | Start |
|---|---|---|
| DEXTECH MEDICAL AB | Ordförande | - |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer | Ordförande | - |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Ordförande | - |
Eir Ventures Danmark ApS
Eir Ventures Danmark ApS Investment ManagersFinance Functions as an alternative investment manager | Privat kapitalinvesterare | 2020-07-01 |
Prexton Therapeutics SA
Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Provides novel therapeutic compounds for treatment of Parkinson disease and other brain disorders | Direktör/Styrelseledamot | - |
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Operates as a biotechnology company that focuses on the development of new ophthalmic drugs and novel therapies based on RNAi technology | Verkställande Direktör | 2024-05-29 |
Tidigare kända positioner av Andreas Segerros
| Företag | Position | Slut |
|---|---|---|
| NICOX SA | Verkställande Direktör | 2024-02-28 |
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board. | Privat kapitalinvesterare | 2019-02-01 |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Specializes in the development, production and marketing of pharmaceutical products | Företagsledare/Principal | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░ ░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Andreas Segerross utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 17 |
|---|---|
CMC Contrast AB
CMC Contrast AB Pharmaceuticals: MajorHealth Technology develops magnetic resonance contrast agents for patients suffering with tumors | Health Technology |
Zyla Life Sciences LLC
Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for patients with acute and chronic pain | Health Technology |
Nicox SA
Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals | Health Technology |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Specializes in the development, production and marketing of pharmaceutical products | Health Technology |
Clinitrac AB
Clinitrac AB Packaged SoftwareTechnology Services Develops wireless patient diaries | Technology Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia, Inc. | |
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
RSPR Pharma AB
RSPR Pharma AB Pharmaceuticals: MajorHealth Technology Develops therapeutics for inflammatory vascular diseases | Health Technology |
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Operates as a biotechnology company that focuses on the development of new ophthalmic drugs and novel therapies based on RNAi technology | Health Technology |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
Prexton Therapeutics SA
Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Provides novel therapeutic compounds for treatment of Parkinson disease and other brain disorders | Health Technology |
Dextech Medical AB
Dextech Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of drug candidates for urologic oncology | Health Technology |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
Eir Ventures Danmark ApS
Eir Ventures Danmark ApS Investment ManagersFinance Functions as an alternative investment manager | Finance |
















